Contract facts
FederalPR-ORD-22-02316: 2226B3E090: ITEM #1-TARGETED RNA-SEQ (TEMPOSEQ) ANALYSES OF WHOLE BODY HOMOGENATE OR PURIFIED RNA SAMPLES AT 97-5000 SAMPLE/TASK ORDER SCALE AND RNASEQ EQUIVALENT SPECIFICATION OF 30 MILLION MAPPED READS PER SAMPLE, 385-3000 GENE ASS is a federal award for Cincinnati Acquisition Div (CAD) held by Biospyder Technologies, Inc. Estimated value $214K ($214K obligated). Current period of performance ends Sep 12, 2023 (potential Sep 29, 2023). Place of performance: CARLSBAD CA.
PR-ORD-22-02316: 2226B3E090: ITEM #1-TARGETED RNA-SEQ (TEMPOSEQ) ANALYSES OF WHOLE BODY HOMOGENATE OR PURIFIED RNA SAMPLES AT 97-5000 SAMPLE/TASK ORDER SCALE AND RNASEQ EQUIVALENT SPECIFICATION OF 30 MILLION MAPPED READS PER SAMPLE, 385-3000 GENE ASS
Recompete timing
PublicCurrent PoP ended Sep 12, 2023 (1074 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordBiospyder Technologies, Inc — $5.2M obligated across 40 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 68HERC22F0511?
68HERC22F0511 (Temposeq and) is a Cincinnati Acquisition Div (CAD) award with a potential value of $214K, currently held by Biospyder Technologies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 68HERC-22-F-0511?
68HERC-22-F-0511 is the dashed form of PIID 68HERC22F0511 (Temposeq and), held by Biospyder Technologies, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 68HERC22F0511?
Cincinnati Acquisition Div (CAD) awarded 68HERC22F0511 to Biospyder Technologies, Inc (potential $214K).
Who is the incumbent on 68HERC22F0511?
Biospyder Technologies, Inc is the incumbent with $5.2M across 40 related awards in SCOUT’s public footprint. The current period of performance ends Sep 12, 2023.
When does Biospyder Technologies, Inc’s 68HERC22F0511 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 12, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.